Literature DB >> 7894079

Postlabeling: a sensitive method for studying DNA adducts and their role in carcinogenesis.

G Keith1, G Dirheimer.   

Abstract

The covalent binding of xenobiotics to DNA is an important trigger of the multistage process that leads to carcinogenesis. 32P-postlabeling represents a highly sensitive method for biomonitoring exposure to genotoxic agents and for cancer risk assessment; it is capable of detecting less than one DNA adduct per human genome. Recent improvements to the technique have shown that the resistance of adducted DNA to enzyme digestion may lead to an overestimation of the number of different adducts present in a sample.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7894079     DOI: 10.1016/0958-1669(95)80002-6

Source DB:  PubMed          Journal:  Curr Opin Biotechnol        ISSN: 0958-1669            Impact factor:   9.740


  4 in total

1.  Determination of genotoxicity of the metabolites of the pesticides Guthion, Sencor, Lorox, Reglone, Daconil and Admire by 32P-postlabeling.

Authors:  R G Shah; J Lagueux; S Kapur; P Levallois; P Ayotte; M Tremblay; J Zee; G G Poirier
Journal:  Mol Cell Biochem       Date:  1997-04       Impact factor: 3.396

Review 2.  Future research directions for evaluating human genetic and cancer risk from environmental exposures.

Authors:  R J Albertini; J A Nicklas; J P O'Neill
Journal:  Environ Health Perspect       Date:  1996-05       Impact factor: 9.031

3.  Genotoxic risk assessment and mechanism of DNA damage induced by phthalates and their metabolites in human peripheral blood mononuclear cells.

Authors:  Paulina Sicińska; Katarzyna Mokra; Katarzyna Wozniak; Jaromir Michałowicz; Bożena Bukowska
Journal:  Sci Rep       Date:  2021-01-18       Impact factor: 4.379

4.  Genotoxic Mechanism of Action of TBBPA, TBBPS and Selected Bromophenols in Human Peripheral Blood Mononuclear Cells.

Authors:  Anna Barańska; Agnieszka Woźniak; Katarzyna Mokra; Jaromir Michałowicz
Journal:  Front Immunol       Date:  2022-04-12       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.